|
Aviation & Flight InformationVioxx Personal Injury Lawsuits
by:
Matthew C. Keegan
Personal injury attorneys representing clients who have allegedly been injured
by the prescription drug Vioxx
are congratulating themselves over a historic judgment rendered recently. On August 19, 2005, a judge awarded the family of Bob Max ernst $253.4 million due to his death from the drug. Vioxx, which had been prescribed most often for inflammatory disease
pain, was withdrawn globally by its maker, Merck, after research trials showed it augmented patients' chances of a heart attack. Though Merck force
the drug off the market in Sept
2004, legal action against this leading pharmaceutical giant wish continue and expand. Let’s take a look at why Vioxx
has become a proceeding lightning rod.
In 1998 as Merck was running clinical trials for Vioxx, institution reports to the FDA expressed
that there were no vessel signals apparent. This meant that there were no telltale signs that the drug could cause heart problems for users. Later, however, it was unconcealed
that an internal study conducted by Merck about the same time – Study 090 – unconcealed
serious vessel problems as compared to patients not taking Vioxx. The study was ne'er
publicized
by Merck as the institution insisted that it was not large enough to provide definitive data.
The following year the FDA gave Vioxx
its approval and the drug became the second nonsteroidal anti-inflammatory medication [or COX-2 inhibitor] to hit the market. Celebrex, another problem drug, was the first.
Merck wide
and thoroughly launched a marketing campaign upon the introduction of Vioxx
to the marketplace. Indeed, by 2003 the drug had entered 80 nations with sales olympian $2.5 billion. Still, there were problems looming as in progress tests conducted by Merck hinted of potential deadly side effects.
As early as 2001, the FDA suggested label warnings be put on prescriptions warning users of potential side effects. In addition, Merck was warned by the FDA to quit dishonourable
physicians just about potential side effects.
As potential problems began to surface, they served as red flags to industry watchdogs, to the FDA, as well as to personal injury attorneys who began to gather evidence to show that Merck was negligent. Indeed, web sites and advertising campaigns – meant to inform and attract patients injured
by the drug – were launched and fairly presently
the internet, radio, television, and print media were flooded with advertisements asking those suspecting harm from Vioxx
to move forward.
With the Sept
2004 announcement that Merck was retreating
Vioxx, personal injury proceeding was well on its way to being established. By early 2005, the 1st cases were filed and the Max ernst case became the 1st Vioxx
causa to be settled.
Wrongful death lawsuits against Vioxx’s maker, Merck, are expected to increase as the result of the Max ernst decision. Personal injury attorneys insist that thousands of former Vioxx
users and/or their families are due compensation for Merck’s neglect. It remains to be seen if juries wish render judgments as large as the Max ernst judgment and whether courts wish uphold these amounts. Nevertheless, it is certain that Merck is in for a long battle that wish reach well on the far side
its US base.
Just just about the Author
Matt Keegan is The Article Writer who write on issues of current appeal as well as aviation and business subjects.
| |
